Moneyview IPO allotment to be finalised today; Check status, GMP and likely listing price
Moneyview's initial public offering (IPO) is set to conclude allotment today, marking a key step for the company's market debut. The subscription figures have been impressive, with Qualified Institutional Buyers (QIBs) showing the highest demand by subscribing 227.45 times their reserved quota. Non-Institutional Investors (NIIs) followed closely with a 115.41 times subscription, while Retail Individual Investors (RIIs) subscribed 19.57 times their portion.
For investors, the high demand from institutional investors suggests strong institutional interest, which can be a positive signal for the stock's performance post-listing. The high subscription levels indicate that the IPO was well-received by the market, potentially leading to a strong listing. However, the final listing price will depend on the grey market premium (GMP) and market conditions at the time of listing.
Investors should watch for the final allotment status and the GMP updates in the coming days. The grey market premium, which reflects the expected listing price, will be crucial in determining the stock's opening price. Market volatility and overall sentiment will also play a significant role in the stock's performance on the listing day.
Key takeaways
- Category: IPO.
- AI reads the tone as positive (potentially bullish) for the stock.
- Assessed as a significant, market-relevant update.
Why it matters
A meaningful update worth tracking. The tone is positive — historically associated with upward pressure, though not predictive. Use the price and stock snapshot to gauge how the market is responding.







